• Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Corporation
Management

BDV, Expanding into the Chinese Offline Market Following Online Success

SHINSEGAE INTERNATIONAL’s in-house cosmetics brand, VIDIVICI, is set to expand its reach into offline channels by leveraging the strong foothold it has established in the Chinese online market. The br…
  • 2026-07-30 08:56:59
  • KYUNG GYEYOUNG
Lifestyle

"New Lotte Speed"... LotteChilsungBeverage Calls All Employees "Pros"

LotteChilsungBeverage is shifting to a role- and performance-based personnel system by introducing “GL” (Growth Level), the Lotte Group’s new personnel system. The plan is to unify all employees under…
  • 2026-07-30 08:47:20
  • kim mi-kyung
Electronics

Huge Bonuses Don’t Come for Free… SK Hanik’s Unprecedented Hiring Drive Causes a Stir

SK hynix is overhauling its recruitment process to select new hires based on their ability to utilize artificial intelligence (AI) and their critical thinking skills in identifying the root causes of …
  • 2026-07-30 08:31:40
  • JAEMIN SONG
Lifestyle

Cellbion Co., Ltd Begins Clinical Trial Combining Keytruda with Merck... Company Valuation Set to Rise

#Cellbion Co., Ltd, a company specializing in radiopharmaceuticals (RPT), is expected to see its corporate value reassessed as it moves to commercialize a prostate cancer treatment and enhance the val…
  • 2026-07-30 08:31:02
  • YU JIN-HEE
Lifestyle

Investors Ask... What Is the Post-IPO Growth Roadmap and What Are the Risk Factors? [In-Depth Look at Ingenia ③]

Ingenia Therapeutics is set to receive milestone payments totaling 50 billion won from Merck by the end of this year. In addition, Edaily’s premium pharma and biotech content platform, PharmEdaily, ha…
  • 2026-07-30 08:11:04
  • YU JIN-HEE
Lifestyle

The Key Technology Merck Has Set Its Sights On... Targeting a $5 Billion Market Value [In-Depth Look at Ingenia, Part 2]

The driving force behind global pharmaceutical and biotech companies’ large-scale investment in Ingenia Therapeutics’ technology lies in “LCIDEC” (Ligand Capture, Internalization, Degradation in EC), …
  • 2026-07-30 08:11:03
  • YU JIN-HEE
Lifestyle

U.S.-Based Biotech Company Sets to Become a Successful KOSDAQ Listing [In-Depth Look at Ingenia, Part 1]

Ingenia Therapeutics (Ingenia), an innovative antibody drug development company headquartered in Boston, U.S., has passed the Korea Exchange’s preliminary review for a KOSDAQ listing and is now moving…
  • 2026-07-30 08:11:02
  • YU JIN-HEE
Lifestyle

Choi Seok-geun, CEO of EyeGene,Inc: “The Nation’s Only Combination of mRNA and GCT Technologies Will Accelerate the Path to a ‘Profitable Biotech Company’”

"We will break free from the limitations of a biotech venture that remains confined to research and development (R&D). By progressively commercializing our proven revenue-generating pipeline—including…
  • 2026-07-30 08:01:02
  • YU JIN-HEE
Lifestyle

Patient Monitoring Market: A Silent Battle... SEERS’ Strategy to Expand into Neurology

As competition in the domestic patient monitoring market intensifies, SEERS TECHNOLOGY(458870)is seeking to differentiate itself by expanding its market presence based on clinical data. Rather than en…
  • 2026-07-30 07:31:02
  • SONG YOUNG-DOO
Electronics

"People Still Line Up Even When Prices Rise"... MLCC Industry Smiles

As the shortage of multilayer ceramic capacitors (MLCCs) for artificial intelligence (AI) servers worsens, major manufacturers are beginning to raise prices in earnest. SamsungElectroMechanics has dec…
  • 2026-07-30 04:00:07
  • JAEMIN SONG
prev 31 32 33 34 35 36 37 38 39 40 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea
English